Trial Profile
Comparison of efficacy of Teneligliptin and Sitagliptin for glucose fluctuation in Type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jul 2018
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 27 Jun 2018 Status changed from recruiting to completed.
- 22 Jul 2016 New trial record